BRADY MOFFETT to Anti-Bacterial Agents
This is a "connection" page, showing publications BRADY MOFFETT has written about Anti-Bacterial Agents.
Connection Strength
3.005
-
Antibiotic Utilization and Efficacy Associated With Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life. Pediatr Infect Dis J. 2021 11 01; 40(11):993-996.
Score: 0.343
-
Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Eur J Clin Pharmacol. 2019 Aug; 75(8):1089-1097.
Score: 0.287
-
Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient. Antimicrob Agents Chemother. 2019 04; 63(4).
Score: 0.286
-
Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2018 10; 19(10):973-980.
Score: 0.277
-
The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit. 2018 06; 40(3):322-329.
Score: 0.270
-
Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E6-10.
Score: 0.206
-
Possible digoxin toxicity associated with concomitant ciprofloxacin therapy. Int J Clin Pharm. 2013 Oct; 35(5):673-6.
Score: 0.193
-
Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals. Pediatr Infect Dis J. 2013 Jan; 32(1):32-5.
Score: 0.186
-
Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease. Ann Pharmacother. 2012 Sep; 46(9):1193-7.
Score: 0.181
-
Vancomycin dosing in obese pediatric patients. Clin Pediatr (Phila). 2011 May; 50(5):442-6.
Score: 0.163
-
Gentamicin dosing for pediatric patients with congenital heart disease. Pediatr Cardiol. 2010 Aug; 31(6):761-5.
Score: 0.156
-
Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Crit Care Explor. 2024 Oct 01; 6(10):e1159.
Score: 0.105
-
Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0189921.
Score: 0.088
-
Population Pharmacokinetics of Vancomycin in the Pediatric Ventricular Assist Device Population. Pediatr Crit Care Med. 2020 08; 21(8):e566-e571.
Score: 0.079
-
Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge. Pediatr Blood Cancer. 2013 Sep; 60(9):1503-6.
Score: 0.047
-
Altered gentamicin serum concentrations in obese pediatric patients. Pediatr Infect Dis J. 2011 Apr; 30(4):347-9.
Score: 0.041
-
Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant. 2011 Jan; 26(1):144-50.
Score: 0.039
-
Once-daily gentamicin dosing in pediatric patients without cystic fibrosis. Pharmacotherapy. 2010 Mar; 30(3):248-53.
Score: 0.038
-
Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
Score: 0.021